454 Sequencing At The Forefront Of Bone Marrow And Stem Cell Therapy Research
Jun 30th 2008Drug InformationGenetics
The Blood Centre Linz, Austria has purchased a Genome Sequencer FLX System from Roche, for use in research on rejection reactions in Bone Marrow and Stem Cell transplantation. Using conventional Sanger sequencing it can take weeks to analyse large DNA regions. The Genome Sequencer FLX System can achieve this task within hours, improving efficiency and reducing costs.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
